The health ministry is aware of media reports about "some" controversy around contracts and regulatory approvals for supply of Covaxin to Brazil, but this relates exclusively to an agreement between a commercial entity Bharat Biotech and another country, Lok Sabha was told on Friday.
Minister of State for Health Bharati Pravin Pawar stated this in a written reply to a question on whether the government has received reports about a "huge" controversy between Bharat Biotech and the Brazilian government over the supply of Rs 2 crore worth of anti-Covid vaccine Covaxin. ‘
"The health ministry is aware of media reports of some controversy around contracts and regulatory approvals for supply of Covaxin to Brazil. This, however, relates exclusively to an agreement between a commercial entity i.e. M/s Bharat Biotech and a foreign country," she said.
Read all the Latest News, Breaking News and Coronavirus News here.
Comments
0 comment